Stockreport

2 ‘Strong Buy' Biotech Stocks With 208% to 329% Upside Potential [Yahoo! Finance]

Kyverna Therapeutics, Inc.  (KYTX) 
PDF Kyverna Therapeutics (KYTX) is advancing its breakthrough CAR T-cell programs in autoimmune diseases, while Janux Therapeutics (JANX) is using its cutting-edge TRACTr, T [Read more]